Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
Sarana Meditama Metropolitan (SAME) - Total Assets
Latest total assets as of September 2025: Rp5.78 Trillion IDR
Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) holds total assets worth Rp5.78 Trillion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sarana Meditama Metropolitan - Total Assets Trend (2009–2024)
This chart illustrates how Sarana Meditama Metropolitan’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sarana Meditama Metropolitan - Asset Composition Analysis
Current Asset Composition (December 2024)
Sarana Meditama Metropolitan's total assets of Rp5.78 Trillion consist of 8.8% current assets and 91.2% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 2.6% |
| Accounts Receivable | Rp267.15 Billion | 4.8% |
| Inventory | Rp52.35 Billion | 0.9% |
| Property, Plant & Equipment | Rp3.98 Trillion | 71.6% |
| Intangible Assets | Rp108.69 Billion | 2.0% |
| Goodwill | Rp449.25 Billion | 8.1% |
Asset Composition Trend (2009–2024)
This chart illustrates how Sarana Meditama Metropolitan's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sarana Meditama Metropolitan's current assets represent 8.8% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2024, up from 2.6% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is property, plant & equipment at 71.6% of total assets.
Sarana Meditama Metropolitan Competitors by Total Assets
Key competitors of Sarana Meditama Metropolitan based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Sarana Meditama Metropolitan - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sarana Meditama Metropolitan generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Sarana Meditama Metropolitan generates $ 0.21 in net profit.
Sarana Meditama Metropolitan - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.62 | 0.77 | 0.45 |
| Quick Ratio | 0.56 | 0.68 | 0.40 |
| Cash Ratio | 0.00 | 0.01 | 0.00 |
| Working Capital | Rp-325.76 Billion | Rp -138.26 Billion | Rp -161.93 Billion |
Sarana Meditama Metropolitan - Advanced Valuation Insights
This section examines the relationship between Sarana Meditama Metropolitan's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.56 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.6% |
| Total Assets | Rp5.56 Trillion |
| Market Capitalization | $56.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sarana Meditama Metropolitan's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sarana Meditama Metropolitan's assets grew by 3.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sarana Meditama Metropolitan (2009–2024)
The table below shows the annual total assets of Sarana Meditama Metropolitan from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp5.56 Trillion | +3.61% |
| 2023-12-31 | Rp5.36 Trillion | +4.37% |
| 2022-12-31 | Rp5.14 Trillion | +3.87% |
| 2021-12-31 | Rp4.95 Trillion | +161.89% |
| 2020-12-31 | Rp1.89 Trillion | -15.37% |
| 2019-12-31 | Rp2.23 Trillion | -11.71% |
| 2018-12-31 | Rp2.53 Trillion | +47.49% |
| 2017-12-31 | Rp1.71 Trillion | +18.10% |
| 2016-12-31 | Rp1.45 Trillion | +20.67% |
| 2015-12-31 | Rp1.20 Trillion | +157.84% |
| 2014-12-31 | Rp466.66 Billion | +23.57% |
| 2013-12-31 | Rp377.65 Billion | +29.88% |
| 2012-12-31 | Rp290.78 Billion | -3.99% |
| 2011-12-31 | Rp302.86 Billion | -5.47% |
| 2010-12-31 | Rp320.38 Billion | -1.33% |
| 2009-12-31 | Rp324.71 Billion | -- |